| Title | The lysis of Trypanosoma brucei brucei by human serum. | | Author(s) | Tomlinson S, Raper J | | Institution | Department of Pathology, NYU Medical Center, New York 10016, USA. stephen.tomlinson@ccmail.med.nyu.edu | | Source | Nat Biotechnol 1996 Jun; 14(6):717-21. | | MeSH | Animals
Blood Physiology
Humans
Immunity, Natural
Research Support, Non-U.S. Gov't
Trypanosoma brucei brucei
Trypanosomiasis
| | Abstract | The natural immunity of humans to the cattle pathogen Trypanosoma brucei brucei, but not to the morphologically indistinguishable human pathogens T. brucei gambiense and T. brucei rhodesiense, is due to the selective killing of the parasite by normal human serum. The factor in human serum that mediates lysis of T. brucei brucei has long been attributed to a minor subclass of high density lipoprotein (HDL). Evidence indicates that the trypanolytic activity of isolated human HDL is due to peroxidase activity of an associated haptoglobin-related protein-hemoglobin complex. However, recent data suggest that the trypanolytic activity of HDL may be completely inhibited in whole human serum, and that trypanolytic activity of norman human serum is due to a second, less well-defined factor of high molecular weight. Current research aimed at understanding the mechanisms of cytotoxicity and the affected metabolic pathways may open new approaches for the development of specific drugs and vaccines against trypanosomiasis. | | Language | eng | | Pub Type(s) | Journal Article
Review
| | PubMed ID | 9630977 |
|
